Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Breast 3Gynecologic 2Gastrointestinal 2Thoracic 1Genitourinary 1

Conditions

Breast Neoplasms 3Ovarian Neoplasms 2Neoplasm Metastasis 2Prostatic Neoplasms 1Pancreatic Neoplasms 1Lung Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Trastuzumab 597Paclitaxel 562Cyclophosphamide 545Docetaxel 479Capecitabine 388Letrozole 350Fulvestrant 311Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 177Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Genetic Profile × Clear all
NCT07555639 2026-04-29

GERSOM

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Active not recruiting
4,000 enrolled
BreastGastrointestinalGynecologic

Breast Neoplasms, Colonic Neoplasms, Ovarian Neoplasms

NCT04905082 2026-03-24

HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics

City of Hope Medical Center

Phase NA Active not recruiting
465 enrolled 11 charts
BreastGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT03080428 2017-08-28

OPTIGEN

UNICANCER

Phase NA Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡